Ex vivo alendronate localization at the mesoporous titania implant/bone interface
- 306 Downloads
An attractive approach in implant technology is local drug delivery, and design of efficient, safe and reliable treatments. Our hitherto strategy has been to coat Ti implants with a thin mesoporous TiO2 film that in turn is loaded with an osteoporosis drug, such as Alendronate (ALN) that is known to suppress osteoclastic activity. This system has proven highly successful and results in excellent osseointegration. However, more detailed information about drug-release and distribution at the bone/implant interface is needed. In this study, 14C-ALN loaded titanium implants were placed up to 8 weeks into rat tibia and the spatial–temporal distribution of the drug was evaluated. Autoradiography data demonstrated a sustained release of 14C-ALN and the released drug remained bound to bone in close vicinity, within 500 micrometers, of the implants. Liquid scintillation counting experiments confirmed that the distal transport of released 14C-ALN was extremely low. The results are favorable as they show that ALN stays for a long time in the vicinity of the implant and may therefore improve for a long time the mechanical fixation of bone anchored implants. Moreover, these findings suggest due to the low systemic spreading a minimal risk of Alendronate related systemic side effects.
KeywordsAlendronate Mesoporous TiO2 Mesoporous Titania Osteoporosis Drug Autoradiographic Image
We gratefully thank the Materials Area of Advance at Chalmers University of Technology and University of Gothenburg, BIOMATCELL VINN Excellence Center for Biomaterials and Cell Therapy, Hjalmar Svensson foundation, and the Swedish Research Council, VR (K2012-52X-09495-25-3, 621-2011-6037) for their financial support. A grant from Knut and Alice Wallenberg Foundation for the acquiring of the FEG-SEM instrument is gratefully acknowledged.
- 2.Rouleau DM, Sandman E, van Riet R, Galatz LM. Management of fractures of the proximal ulna. J Am Acad Orthop Surg. 2013;21:149–60.Google Scholar
- 3.Porter JR, Ruckh TT, Popat KC. Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnol Prog. 2009;25:1539–60.Google Scholar
- 5.Colilla M, Manzano M, Vallet-Regi M. Recent advances in ceramic implants as drug delivery systems for biomedical applications. Int J Nanomedicine. 2008;3:403–14.Google Scholar
- 21.Wennerberg A, Jimbo R, Allard S, Skarnemark G, Andersson M. In vivo stability of hydroxyapatite nanoparticles coated on titanium implant surfaces. Int J Oral Maxillofac Implants. 2011;26:1161–6.Google Scholar
- 26.Fazil M, Baboota S, Sahni JK, Ameeduzzafar, Ali J. Bisphosphonates: therapeutics potential and recent advances in drug delivery. Drug Deliv. 2014.Google Scholar